Floatz logo

L-Ornithine-L-Aspartate

Hepatic Encephalopathy

Qurratul Ain JamilUNKNOWNPhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Hepatic Encephalopathy cohort.

Asset / SponsorPhaseRating
Rifaximin
General Hospital of Shenyang Military Region
Phase 4BBB
L-Ornithine L-Aspartate
Jinnah Postgraduate Medical Centre
Phase 4BBB
Lactulose
General Hospital of Shenyang Military Region
Phase 4BBB
Normal Human Serum Albumin
General Hospital of Shenyang Military Region
Phase 4BB
LACTOSE
Centro Regional para el Estudio de las Enfermedades Digestivas
Phase 4BB

View all 46 →

Same molecule, other indications

L-Ornithine-L-Aspartate is also rated in:

cirrhosis of liverDormant
B
Indicative · Phase 2/3
60 / 100
View asset →
portal hypertensionDormant
B
Indicative · Phase 2/3
58 / 100
View asset →
esophageal varices with bleedingDormant
NR
Indicative · Phase 2/3
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →